The report’s scope includes an overview of the global market for animal therapeutics and diagnostics along with an analysis of global market trends; the report uses 2022 as the base year and forecasts 2023 the compound annual growth rate (CAGR) for 2023 to 2028.
The report is designed to be a helpful business tool that will provide a thorough evaluation of the animal therapeutics and diagnostics market. The geographical scope of this study is worldwide, with special interest for markets, trends, and statistics by key geographical regions such as the United States, European countries, and Brazil, Japan, and Australia. The report identifies markets in four segments: vaccines, pharmaceuticals, feed additives, and diagnostics. For the purpose of this study, diagnostics include products that are used at the point of care and are considered rapid tests or kits, in-clinic analyzers, and imaging equipment. Each market segment provides detailed information based on product categories, use of products, forecasts, and competitive analyses.
- 56 data tables and 143 additional tables
- An overview of the global market for animal therapeutics and diagnostics
- Estimates of the market size and analyses of global market trends with data from 2020-2023, and projections of compound annual growth rates (CAGRs) through 2028
- Assessment of market drivers, opportunities, and restraints, and current trends and technological advances
- Evaluation of the market with a focus of global production of animal healthcare products, vaccines, feed additives, therapeutic and diagnostic drugs
- Analyses of the market shares of the leading suppliers of animal vaccines and therapeutic drugs, the competitive landscape, market positioning, revenue sales and product segments
- Discussion of the role of major providers of vaccines and companion animal products approved for a wide variety of indications, and emerging technologies in the market.
- Analyses of ESG trends and patents granted for animal health products
- Profiles of the leading companies, including Boehringer Ingelheim, DSM Nutritional Products, Merck & Co. Inc., Phibro Animal Health Corp., Virbac S.A., and Zoetis Services LLC